Form 4: SEALSQ Corp Insider Trades Under 10b5-1 Plan

SEALSQ Corp Vice President Jean-Pierre Enguent executed trades involving ordinary shares and stock options under a pre-arranged Rule 10b5-1 trading plan.

Summary

• Jean-Pierre Enguent, Vice President of R&D at SEALSQ Corp, reported transactions on July 6, 2026, and July 8, 2026.
• On July 6, 2026, Enguent acquired 15,000 ordinary shares at a price of $0.01 per share, totaling $150.
• Also on July 6, 2026, Enguent exercised an employee stock option, acquiring 15,000 ordinary shares under the plan, with a conversion price of $0.01.
• On July 8, 2026, Enguent disposed of 15,000 ordinary shares at a weighted average price of $2.8178 per share, with individual sales ranging from $2.73 to $2.91.
• These transactions were conducted under a Rule 10b5-1 trading plan adopted on October 13, 2025.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral. While the sale of shares by an executive can sometimes be perceived negatively, the execution under a Rule 10b5-1 plan and the significant profit realized from option exercises suggest a planned financial management activity rather than a negative outlook on the company.

Positives

• The reporting person is utilizing a Rule 10b5-1 trading plan, which is designed to provide an affirmative defense against allegations of insider trading by establishing pre-arranged trading schedules.
• The exercise of stock options at a low price ($0.01) suggests potential favorable terms for management compensation.
• The weighted average sale price of $2.8178 indicates a significant increase from the exercise price of the options.

Negatives

• The disposal of 15,000 ordinary shares by a key executive could be interpreted negatively by the market, despite being part of a pre-planned strategy.
• The filing does not provide details on the overall number of shares held by the reporting person before or after these transactions, making it difficult to assess the scale of the disposal relative to their total holdings.

Risks

• The execution of a Rule 10b5-1 plan, while a protective measure, still involves the sale of company stock by an insider, which can sometimes be perceived as a lack of confidence in future price appreciation.
• The weighted average sale price is subject to fluctuations within the reported range, meaning the actual proceeds could vary.

Future Outlook

The filing itself does not contain forward-looking statements or guidance. The Rule 10b5-1 plan implies a pre-determined strategy for future transactions, but specific outcomes are not detailed.

Management Comments

• The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 13, 2025.
• The option exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 13, 2025.

Industry Context

StockSavvy.ai notes that the use of Rule 10b5-1 plans by executives is a common practice in the semiconductor and technology sectors to manage personal stock portfolios while adhering to insider trading regulations. This filing indicates SEALSQ Corp's executive team is actively managing their holdings within established compliance frameworks.

Stakeholder Impact

• Shareholders: The sale of shares by an executive, even under a 10b5-1 plan, may lead to short-term market perception shifts. However, the profit realized suggests the executive believes the stock has performed well.
• Employees: The exercise of stock options by management can be seen as a positive indicator of the company's performance and the value of its equity compensation plans.
• Management: The filing details the execution of a pre-planned strategy for managing personal equity holdings.

Next Steps

• The reporting person may continue to execute transactions under the Rule 10b5-1 plan as scheduled.
• Further Form 4 filings will be required for any subsequent changes in beneficial ownership.

Key Dates

Keywords

SEALSQ Corp, Form 4, Insider Trading, Rule 10b5-1, Stock Options, Ordinary Shares, Jean-Pierre Enguent, SEC Filing, Beneficial Ownership